Skip to content
HowShorted

Perspective Therapeutics, Inc. short interest in 2023

In 2023, Perspective Therapeutics, Inc.'s disclosed short interest ran from 0.29% of shares outstanding on 13 Jan 2023 to 0.69% on 29 Dec 2023, a change of +0.40 percentage points. The year's high was 0.91% on 28 Apr 2023 and its low 0.19% on 15 Feb 2023, averaging 0.60% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.12 days on 14 Jul 2023. Full history: Perspective Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Perspective Therapeutics, Inc. in 2023

2023 in figures

Start of year
0.29% (13 Jan 2023)
End of year
0.69% (29 Dec 2023)
Change
+0.40 pp
High
0.91% (28 Apr 2023)
Low
0.19% (15 Feb 2023)
Average
0.60%
Highest days to cover
10.12 (14 Jul 2023)
SEC filings marked
6

Every report in 2023

Perspective Therapeutics, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.29%2.11
31 Jan 20230.29%1.47
15 Feb 20230.19%1.00
28 Apr 20230.91%5.06results (8-K)
15 May 20230.69%5.1310-Q filed
31 May 20230.64%3.76
15 Jun 20230.56%6.57
30 Jun 20230.61%3.54
14 Jul 20230.59%10.12
31 Jul 20230.61%9.04
15 Aug 20230.63%4.6010-Q filed, results (8-K)
31 Aug 20230.56%4.10
15 Sep 20230.56%5.60
29 Sep 20230.72%1.00
13 Oct 20230.69%6.31
31 Oct 20230.73%6.55
15 Nov 20230.69%6.1410-Q filed, results (8-K)
30 Nov 20230.66%7.59
15 Dec 20230.64%4.84
29 Dec 20230.69%1.31

See also: Perspective Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.